title: [Infectious complications in patients with iatrogenic diseases of the trachea and esophagus].
abstract: Methods for microbiological monitoring could analyze the microflora isolated in 372 patients with iatrogenic diseases of the trachea and esophagus, who were treated at the Department for Surgery of the Lung and Mediastinum, Acad. B. V. Petrovsky Russian Research Center of Surgery, Russian Academy of Medical Sciences, in 2003 to 2009. Major groups of microorganisms colonizing the tracheobronchial tree in patients who had undergone long-term resuscitation, injuries, surgery, etc. and in those who had admitted to the department from other clinics are identified. The main clinically significant microorganisms isolated during the pathological process in this area were Staphylococcus epidermadis (3.9-13.3%), St. aureus (12.4-21.1%), Pseudomonas eruginosa (9.2-17.5%), and Candida fungi (7.8-12.2%). This indicates the greater importance of the fungal microflora and its representatives' resistance to the most commonly used drugs. Rational antibacterial therapy regimens are proposed in relation to the type of microorganisms colonizing the tracheobronchial tree.
authors.forename: V D
authors.initials: VD
authors.lastname: Parshin
authors.forename: N S
authors.initials: NS
authors.lastname: Bogomolova
authors.forename: G A
authors.initials: GA
authors.lastname: Vishnevskaia
authors.forename: L V
authors.initials: LV
authors.lastname: Bol'shakov
authors.forename: T D
authors.initials: TD
authors.lastname: Oreshkina
authors.forename: S M
authors.initials: SM
authors.lastname: Kuznetsova
authors.forename: S S
authors.initials: SS
authors.lastname: Chernyĭ
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002177:Candidiasis / Q000209:etiology / Q000382:microbiology*; D004935:Esophageal Diseases / Q000209:etiology / Q000382:microbiology*; D015725:Fluconazole / Q000494:pharmacology; D006801:Humans; D007049:Iatrogenic Disease; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000209:etiology / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D012121:Respiration, Artificial / Q000009:adverse effects; D013203:Staphylococcal Infections / Q000209:etiology / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D013212:Staphylococcus epidermidis / Q000187:drug effects / Q000302:isolation & purification; D014133:Tracheal Diseases / Q000209:etiology / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D015725:Fluconazole